Google's new Graph Foundation Model delivers up to 40 times greater precision and has been tested at scale on spam detection.

Vertex Pharmaceuticals (VRTX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to ...

Discover why Vertex Pharmaceuticals outperforms amid biotech sector decline. Explore growth drivers, risks, and the ...

Vertex Pharmaceuticals Inc. closed 10.71% below its 52-week high of $519.88, which the company reached on November 8th.

The stock's fall snapped a three-day winning streak.

Vertex VERX shares rallied 5% in the last trading session to close at $36.21. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session.

See the latest Vertex Pharmaceuticals Inc stock price (VRTX:XNAS), related news, valuation, dividends and more to help you make your investing decisions.

Three people with type 1 diabetes who received Vertex Pharma’s islet cell therapy VX-880 were able to come off insulin within a year.

Discover real-time Vertex Pharmaceuticals Incorporated Common Stock (VRTX) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead with ...

Vertex Pharmaceuticals’ stock dipped 1.73%, underperforming the S&P 500’s mild loss, despite solid monthly gains. Investors ...

Vertex Pharmaceuticals is currently pushing against the $467.85 resistance level as its stock maintains an upward trend.